Central venous catheter practice patterns for dialysis access vary by patient sex, race
Click Here to Manage Email Alerts
Racial and sex differences exist for patients on hemodialysis regarding time spent on a central venous catheter and the likelihood of transferring to permanent access, according to study results.
“Of incident hemodialysis patients in the United States, 80% start hemodialysis on a central venous catheter (CVC),” Shipra Arya, MD, FACS, of Stanford University School of Medicine, and colleagues wrote. “Despite a national push toward arteriovenous fistula and arteriovenous graft use, little is known about the characteristics and natural history of patients who start hemodialysis on a CVC.”
Using data from the US Renal Data System, researchers identified 74,194 Medicare-eligible patients who initiated dialysis between July 1, 2010 (the date when CMS began requiring dialysis claim bills to include type of vascular access being used) and Dec. 31, 2013.
While the mean time spent on CVC for the entire cohort was 220.1 days, researchers observed women spent a longer time on CVC than men (mean 229.5 days vs. 211.5 days) and that black (mean 243.2 days) and Hispanic patients (mean 237.6 days) spent a longer time on CVC compared with white patients (mean 209.3 days). It was further determined that black women spent the longest time on CVC, while white men spent the least amount of time (245.8 vs. 200.8 days).
At 1 year following dialysis initiation, 32.7% of all patients transitioned to an arteriovenous fistula; 10.8% transitioned to an arteriovenous graft; 32.1% stayed on a CVC and 24.5% died. Researchers found women and black patients were significantly less likely than men to transition to a fistula and more likely to transition to a graft. Mortality at 1 year was higher in white patients.
Researchers noted risk factors for transition to arteriovenous graft rather than arteriovenous fistula included advancing age and hospitalization within the past year. In addition, patients who received early nephrology care (before ESKD) had a higher likelihood of transition to permanent access with either fistula or graft.
Furthermore, researchers argued that while biologic reasons may partially explain these differences (with previous studies reporting more difficulty establishing successful access in black patients and women), “the longer CVC time may also reflect system-related factors such as poor access to care.”
They concluded, “Because prolonged catheter use [ 90 days] is associated with decreased survival and failure of future access modalities, there is an urgent need for clinicians and policymakers to shift focus to minimizing catheter use for patients starting hemodialysis through CVC.” – by Melissa J. Webb
Disclosures: The authors report no relevant financial disclosures.